Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.

ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.

Ma F, Bi L, Yang G, Zhang M, Liu C, Zhao Y, Wang Y, Wang J, Bai Y, Zhang Y.

Oncol Rep. 2014 Sep;32(3):1071-7. doi: 10.3892/or.2014.3313.

PMID:
25017610
2.

Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.

Zhu XL, Liang L, Ding YQ.

Int J Colorectal Dis. 2008 Nov;23(11):1041-7. doi: 10.1007/s00384-008-0520-2.

PMID:
18665374
3.

ZNF703 acts as an oncogene that promotes progression in gastric cancer.

Yang G, Ma F, Zhong M, Fang L, Peng Y, Xin X, Zhong J, Yuan F, Gu H, Zhu W, Zhang Y.

Oncol Rep. 2014 Apr;31(4):1877-82. doi: 10.3892/or.2014.2997.

PMID:
24481460
4.

Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.

Gao JY, Song BR, Peng JJ, Lu YM.

World J Gastroenterol. 2012 Nov 7;18(41):5965-71. doi: 10.3748/wjg.v18.i41.5965.

5.

ST13, a proliferation regulator, inhibits growth and migration of colorectal cancer cell lines.

Bai R, Shi Z, Zhang JW, Li D, Zhu YL, Zheng S.

J Zhejiang Univ Sci B. 2012 Nov;13(11):884-93. doi: 10.1631/jzus.B1200037.

6.

CXCL10 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Xu Y, Cai S.

Mol Biol Rep. 2010 Jul;37(6):3029-36. doi: 10.1007/s11033-009-9873-z.

PMID:
19821051
7.

FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.

Chu XY, Zhu ZM, Chen LB, Wang JH, Su QS, Yang JR, Lin Y, Xue LJ, Liu XB, Mo XB.

Acta Histochem. 2012 Dec;114(8):755-62. doi: 10.1016/j.acthis.2012.01.002.

PMID:
22326401
8.

Expression of SATB1 promotes the growth and metastasis of colorectal cancer.

Zhang Y, Tian X, Ji H, Guan X, Xu W, Dong B, Zhao M, Wei M, Ye C, Sun Y, Yuan X, Yang C, Hao C.

PLoS One. 2014 Jun 27;9(6):e100413. doi: 10.1371/journal.pone.0100413.

9.

Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.

Likui W, Hong W, Shuwen Z.

J Gastrointest Surg. 2010 Jan;14(1):74-81. doi: 10.1007/s11605-009-1035-z.

PMID:
19763701
10.

Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer.

Lu J, Zhao J, Feng H, Wang P, Zhang Z, Zong Y, Ma J, Zheng M, Lu A.

Dig Dis Sci. 2014 Sep;59(9):2153-62. doi: 10.1007/s10620-014-3138-y.

PMID:
24705643
11.

Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.

Xu J, Wang F, Jiang H, Jiang Y, Chen J, Qin J.

J Gastrointest Surg. 2015 Aug;19(8):1484-96. doi: 10.1007/s11605-015-2767-6.

PMID:
26022775
12.

Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.

Zeng YF, Xiao YS, Lu MZ, Luo XJ, Hu GZ, Deng KY, Wu XM, Xin HB.

Exp Mol Pathol. 2015 Apr;98(2):260-7. doi: 10.1016/j.yexmp.2015.03.008.

PMID:
25758200
13.

GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.

Shen F, Li J, Cai W, Zhu G, Gu W, Jia L, Xu B.

Oncol Rep. 2013 Sep;30(3):1355-61. doi: 10.3892/or.2013.2544.

PMID:
23784465
14.

Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.

Zhang F, Yang Q, Meng F, Shi H, Li H, Liang Y, Han A.

Mol Carcinog. 2013 Aug;52(8):603-10. doi: 10.1002/mc.21894.

PMID:
22431469
15.

miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.

Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y, Wang QS, Li SB, Xiao GC, Tong SL.

World J Gastroenterol. 2014 Jun 7;20(21):6515-22. doi: 10.3748/wjg.v20.i21.6515.

16.

UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.

Wang F, Yang YZ, Shi CZ, Zhang P, Moyer MP, Zhang HZ, Zou Y, Qin HL.

Ann Surg Oncol. 2012 Aug;19(8):2753-62. doi: 10.1245/s10434-011-2194-1.

PMID:
22219067
17.

Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.

Wang W, Xing C.

Pathol Res Pract. 2016 Aug;212(8):690-5. doi: 10.1016/j.prp.2016.05.003. Epub 2016 May 12.

PMID:
27461828
18.

Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Wang Z, Xu Y, Wang B, Huang W, Cai S.

Biosci Rep. 2010 Dec;30(6):383-90. doi: 10.1042/BSR20090129.

PMID:
20001967
19.

RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.

Imaoka H, Toiyama Y, Saigusa S, Kawamura M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Inoue Y, Mohri Y, Kusunoki M.

Carcinogenesis. 2015 Mar;36(3):346-54. doi: 10.1093/carcin/bgu327.

PMID:
25568185
20.

Supplemental Content

Support Center